Vanguard Global Advisers’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$728K Buy
20,465
+3,941
+24% +$155K ﹤0.01% 1910
2026
Q2
$767K Hold
16,524
– – ﹤0.01% 1896
2026
Q1
$405K Buy
+16,524
New +$391K ﹤0.01% 2140

Other funds holding ASTH

Vanguard Global Advisers's ASTH Position: Q3 2026 in Review

Vanguard Global Advisers increased its Astrana Health (ASTH) stake by 24% in Q3 2026, buying an estimated $155K and bringing the position to 20,465 shares worth $728K. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Vanguard Global Advisers first reported a position in ASTH in Q1 2026 and has held it in 3 quarters since. The position peaked at $767K in Q2 2026. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Vanguard Global Advisers held 20,465 shares of Astrana Health worth $728K as of Q3 2026.
  • Vanguard Global Advisers bought 3,941 Astrana Health shares in Q3 2026, an estimated $155K.
  • Astrana Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1910 holding.
  • Vanguard Global Advisers first reported a position in Astrana Health in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Astrana Health position peaked at $767K in Q2 2026.
  • 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.